= 0 1 0 1 O
< 1 2 1 2 O
3 3 4 3 4 B-upper_bound
months 5 11 5 11 I-upper_bound
from 12 16 12 16 O
a 17 18 17 18 O
transurethral 19 32 19 32 B-treatment
resection 33 42 33 42 I-treatment
of 43 45 43 45 I-treatment
the 46 49 46 49 I-treatment
prostate 50 58 50 58 I-treatment
( 59 60 59 60 I-treatment
TURP 60 64 60 64 I-treatment
) 64 65 64 65 I-treatment
procedure 66 75 66 75 I-treatment

Acute 0 5 76 81 B-chronic_disease
bacterial 6 15 82 91 I-chronic_disease
or 16 18 92 94 O
fungal 19 25 95 101 B-chronic_disease
infection 26 35 102 111 I-chronic_disease
requiring 36 45 112 121 O
intravenous 46 57 122 133 B-treatment
antibiotics 58 69 134 145 I-treatment
at 70 72 146 148 O
the 73 76 149 152 O
time 77 81 153 157 O
of 82 84 158 160 O
registration 85 97 161 173 O

American 0 8 174 182 B-clinical_variable
Urological 9 19 183 193 I-clinical_variable
Association 20 31 194 205 I-clinical_variable
( 32 33 206 207 I-clinical_variable
AUA 33 36 207 210 I-clinical_variable
) 36 37 210 211 I-clinical_variable
= 38 39 212 213 O
< 39 40 213 214 O
18 41 43 215 217 B-upper_bound
with 44 48 218 222 O
or 49 51 223 225 O
without 52 59 226 233 O
medical 60 67 234 241 O
management 68 78 242 252 O

Clinical 0 8 253 261 B-clinical_variable
stage 9 14 262 267 I-clinical_variable
= 15 16 268 269 O
< 16 17 269 270 O
T2b 18 21 271 274 B-cancer
( 22 23 275 276 O
American 23 31 276 284 O
Joint 32 37 285 290 O
Committee 38 47 291 300 O
on 48 50 301 303 O
Cancer 51 57 304 310 O
[ 58 59 311 312 O
AJCC 59 63 312 316 O
] 63 64 316 317 O
7th 65 68 318 321 O
Edition 69 76 322 329 O
Staging 77 84 330 337 O
Manual 85 91 338 344 O
) 91 92 344 345 O
and 93 96 346 349 O
no 97 99 350 352 O
radiographic 100 112 353 365 B-treatment
evidence 113 121 366 374 O
of 122 124 375 377 O
T3 125 127 378 380 B-cancer
or 128 130 381 383 O
T4 131 133 384 386 B-cancer
disease 134 141 387 394 O

Clinical 0 8 395 403 O
stage 9 14 404 409 B-cancer
N0 15 17 410 412 I-cancer
, 17 18 412 413 I-cancer
M0 19 21 414 416 I-cancer

Confirmation 0 12 417 429 O
that 13 17 430 434 O
insurance 18 27 435 444 O
will 28 32 445 449 O
cover 33 38 450 455 O
SBRT 39 43 456 460 B-treatment
through 44 51 461 468 O
normal 52 58 469 475 O
hospital 59 67 476 484 O
authorization 68 81 485 498 O
process 82 89 499 506 O

Crohn 0 5 507 512 B-chronic_disease
's 5 7 512 514 I-chronic_disease
disease 8 15 515 522 I-chronic_disease
or 16 18 523 525 O
ulcerative 19 29 526 536 B-chronic_disease
colitis 30 37 537 544 I-chronic_disease

Eastern 0 7 545 552 B-clinical_variable
Cooperative 8 19 553 564 I-clinical_variable
Oncology 20 28 565 573 I-clinical_variable
Group 29 34 574 579 I-clinical_variable
( 35 36 580 581 I-clinical_variable
ECOG 36 40 581 585 I-clinical_variable
) 40 41 585 586 I-clinical_variable
performance 42 53 587 598 I-clinical_variable
status 54 60 599 605 I-clinical_variable
0 61 62 606 607 B-lower_bound
- 62 63 607 608 O
1 63 64 608 609 B-upper_bound

FOR 0 3 610 613 O
ARM 4 7 614 617 O
A 8 9 618 619 O
: 9 10 619 620 O
Inability 11 20 621 630 O
to 21 23 631 633 O
obtain 24 30 634 640 O
a 31 32 641 642 O
planning 33 41 643 651 O
MRI 42 45 652 655 B-treatment
or 46 48 656 658 O
a 49 50 659 660 O
planning 51 59 661 669 O
MRI 60 63 670 673 O
of 64 66 674 676 O
sufficient 67 77 677 687 O
quality 78 85 688 695 O
to 86 88 696 698 O
allow 89 94 699 704 O
identification 95 109 705 719 O
of 110 112 720 722 O
the 113 116 723 726 O
peripheral 117 127 727 737 O
zone 128 132 738 742 O
and 133 136 743 746 O
urethra 137 144 747 754 O
, 144 145 754 755 O
or 146 148 756 758 O
inability 149 158 759 768 O
to 159 161 769 771 O
adequately 162 172 772 782 O
fuse 173 177 783 787 O
the 178 181 788 791 O
MRI 182 185 792 795 O
to 186 188 796 798 O
the 189 192 799 802 O
planning 193 201 803 811 O
CT 202 204 812 814 B-treatment
scan 205 209 815 819 I-treatment

Gleason 0 7 820 827 B-clinical_variable
score 8 13 828 833 I-clinical_variable
= 14 15 834 835 O
< 15 16 835 836 O
7 17 18 837 838 B-upper_bound
, 18 19 838 839 O
no 20 22 840 842 O
tertiary 23 31 843 851 B-clinical_variable
pattern 32 39 852 859 I-clinical_variable
> 40 41 860 861 O
= 41 42 861 862 O
5 43 44 863 864 B-lower_bound

Histologically 0 14 865 879 O
confirmed 15 24 880 889 O
diagnosis 25 34 890 899 O
of 35 37 900 902 O
adenocarcinoma 38 52 903 917 B-cancer
of 53 55 918 920 I-cancer
the 56 59 921 924 I-cancer
prostate 60 68 925 933 I-cancer
and 69 72 934 937 O
most 73 77 938 942 O
recent 78 84 943 949 O
biopsy 85 91 950 956 B-treatment
within 92 98 957 963 O
180 99 102 964 967 B-upper_bound
days 103 107 968 972 I-upper_bound
of 108 110 973 975 O
study 111 116 976 981 O
enrollment 117 127 982 992 O

History 0 7 993 1000 O
/ 7 8 1000 1001 O
physical 8 16 1001 1009 O
examination 17 28 1010 1021 O
with 29 33 1022 1026 O
digital 34 41 1027 1034 O
rectal 42 48 1035 1041 O
examination 49 60 1042 1053 O
of 61 63 1054 1056 O
the 64 67 1057 1060 O
prostate 68 76 1061 1069 O
within 77 83 1070 1076 O
90 84 86 1077 1079 B-upper_bound
days 87 91 1080 1084 I-upper_bound
prior 92 97 1085 1090 I-upper_bound
to 98 100 1091 1093 O
study 101 106 1094 1099 O
enrollment 107 117 1100 1110 O

Maximum 0 7 1111 1118 O
PSA 8 11 1119 1122 B-clinical_variable
= 12 13 1123 1124 O
< 13 14 1124 1125 O
20 15 17 1126 1128 B-upper_bound
ng 18 20 1129 1131 I-upper_bound
/ 20 21 1131 1132 I-upper_bound
ml 21 23 1132 1134 I-upper_bound
( 24 25 1135 1136 O
not 25 28 1136 1139 O
within 29 35 1140 1146 O
20 36 38 1147 1149 B-upper_bound
days 39 43 1150 1154 I-upper_bound
after 44 49 1155 1160 O
biopsy 50 56 1161 1167 O
) 56 57 1167 1168 O

Most 0 4 1169 1173 O
recent 5 11 1174 1180 O
prostate 12 20 1181 1189 B-clinical_variable
specific 21 29 1190 1198 I-clinical_variable
antigen 30 37 1199 1206 I-clinical_variable
( 38 39 1207 1208 I-clinical_variable
PSA 39 42 1208 1211 I-clinical_variable
) 42 43 1211 1212 I-clinical_variable
within 44 50 1213 1219 O
60 51 53 1220 1222 B-upper_bound
days 54 58 1223 1227 I-upper_bound
of 59 61 1228 1230 O
enrollment 62 72 1231 1241 O

Previous 0 8 1242 1250 B-treatment
pelvic 9 15 1251 1257 I-treatment
irradiation 16 27 1258 1269 I-treatment
, 27 28 1269 1270 O
prostate 29 37 1271 1279 B-treatment
brachytherapy 38 51 1280 1293 I-treatment

Previous 0 8 1294 1302 O
radical 9 16 1303 1310 O
surgery 17 24 1311 1318 B-treatment
( 25 26 1319 1320 O
prostatectomy 26 39 1320 1333 B-treatment
) 39 40 1333 1334 O
or 41 43 1335 1337 O
cryosurgery 44 55 1338 1349 B-treatment
for 56 59 1350 1353 O
prostate 60 68 1354 1362 B-cancer
cancer 69 75 1363 1369 I-cancer

Prior 0 5 1370 1375 O
or 6 8 1376 1378 O
concurrent 9 19 1379 1389 O
invasive 20 28 1390 1398 B-cancer
malignancy 29 39 1399 1409 I-cancer
( 40 41 1410 1411 O
except 41 47 1411 1417 O
non 48 51 1418 1421 B-cancer
- 51 52 1421 1422 I-cancer
melanomatous 52 64 1422 1434 I-cancer
skin 65 69 1435 1439 I-cancer
cancer 70 76 1440 1446 I-cancer
) 76 77 1446 1447 O
or 78 80 1448 1450 O
lymphomatous 81 93 1451 1463 B-cancer
/ 93 94 1463 1464 O
hematogenous 94 106 1464 1476 B-cancer
malignancy 107 117 1477 1487 I-cancer
unless 118 124 1488 1494 O
continually 125 136 1495 1506 O
disease 137 144 1507 1514 O
free 145 149 1515 1519 O
for 150 153 1520 1523 O
a 154 155 1524 1525 O
minimum 156 163 1526 1533 O
of 164 166 1534 1536 O
5 167 168 1537 1538 B-lower_bound
years 169 174 1539 1544 I-lower_bound

Prosthetic 0 10 1545 1555 B-treatment
implants 11 19 1556 1564 I-treatment
in 20 22 1565 1567 I-treatment
the 23 26 1568 1571 I-treatment
pelvic 27 33 1572 1578 I-treatment
region 34 40 1579 1585 I-treatment
that 41 45 1586 1590 O
the 46 49 1591 1594 O
investigator 50 62 1595 1607 O
feels 63 68 1608 1613 O
will 69 73 1614 1618 O
impede 74 80 1619 1625 O
treatment 81 90 1626 1635 B-treatment
, 90 91 1635 1636 O
planning 92 100 1637 1645 O
, 100 101 1645 1646 O
or 102 104 1647 1649 O
delivery 105 113 1650 1658 O
( 114 115 1659 1660 O
e.g. 115 119 1660 1664 O
, 119 120 1664 1665 O
an 121 123 1666 1668 O
artificial 124 134 1669 1679 O
hip 135 138 1680 1683 O
) 138 139 1683 1684 O

Scleroderma 0 11 1685 1696 B-chronic_disease

Significant 0 11 1697 1708 O
urinary 12 19 1709 1716 B-chronic_disease
obstruction 20 31 1717 1728 I-chronic_disease
( 32 33 1729 1730 O
i.e. 33 37 1730 1734 O
AUA 38 41 1735 1738 B-clinical_variable
symptom 42 49 1739 1746 I-clinical_variable
score 50 55 1747 1752 I-clinical_variable
> 56 57 1753 1754 O
18 58 60 1755 1757 B-lower_bound
) 60 61 1757 1758 O

Up 0 2 1759 1761 O
to 3 5 1762 1764 O
a 6 7 1765 1766 O
total 8 13 1767 1772 O
of 14 16 1773 1775 O
year 17 21 1776 1780 O
of 22 24 1781 1783 O
androgen 25 33 1784 1792 B-treatment
deprivation 34 45 1793 1804 I-treatment
allowed 46 53 1805 1812 O

